HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Takes "Baby Steps" Toward More Open Supplement Regulation

This article was originally published in The Tan Sheet

Executive Summary

China's health product regulators are taking "baby steps" toward more streamlined approval of supplements, but multi-ingredient products likely will face a series of hurdles before market, says Jeff Crowther, former executive director of the Natural Products Association's Beijing office

You may also be interested in...



China Market Veteran Crowther Lobbies For Nutritional Product Regs

The U.S.-China Health Products Association is pushing China's regulators to publish health food regulations to help spur Western firms' entry into the country.

USANA Acquires BabyCare For Faster Route To China

Multi-level dietary supplement marketer USANA Health Sciences chooses a faster route over the "arduous" licensing approach to enter China by acquiring nutritional product firm BabyCare Ltd

Melamine In U.S. Could Pose More Risk To Food Safety Regime Than Infants

FDA says trace amounts of melamine found in U.S.-manufactured infant formula poses no danger, but the discovery will likely lead to a renewed push for food safety oversight and possibly for a separate food safety agency

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel